GlassScriptPhysician profile
Joseph B Byrne
NPI 1861685463
$4,273.93
in general payments reported to CMS, 2019-2025
24 companies · $1,413 in 2025
The $1,413 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $219 · 2021: $664 · 2022: $806 · 2023: $449 · 2024: $292 · 2025: $1,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Travel and Lodging: $808 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.82 |
| Travel and Lodging | $807.96 |
| Education | $182.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,048.80 | 2019-2025 | Mako, Triathlon, Aequalis Perform Reversed |
| Zimmer Biomet Holdings, INC. | $1,007.48 | 2025 | Persona, Osseotite |
| Depuy Synthes Sales INC. | $308.83 | 2019-2025 | Orthovisc, Monovisc |
| Elite Orthopedics, LLC | $179.51 | 2020-2025 | |
| Smith+Nephew, INC. | $176.75 | 2019-2025 | Pico 14, Pico, "Acticoat 4"" X 4""" |
| Pacira Pharmaceuticals Incorporated | $93.49 | 2023-2025 | Exparel, Zilretta, Iovera |
| Medical Device Business Services, INC. | $80.38 | 2020 | |
| Ferring Pharmaceuticals INC. | $45.49 | 2025 | Euflexxa |
| Baudax Bio INC. | $34.70 | 2021 | |
| Ermi LLC | $30.34 | 2022 | |
| Molnlycke Health Care US, LLC | $28.69 | 2022 | |
| Pacira Therapeutics, INC. | $28.40 | 2019 | |
| Solventum Corporation | $24.17 | 2025 | Prevena |
| Pfizer INC. | $21.58 | 2020 | |
| Amgen INC. | $20.24 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $19.66 | 2025 | Gelsyn-3 |
| Orthalign INC | $19.04 | 2024 | Orthalign Plus |
| Heron Therapeutics, INC. | $17.43 | 2021 | |
| Highridge Medical LLC | $17.07 | 2024 | Biomet Ebi Bone Healing System |
| Sanara Medtech INC. | $16.30 | 2024 | Celleraterx |
| Medtronic, INC. | $16.04 | 2025 | Inceptiv |
| Heraeus Medical, LLC. | $15.91 | 2024 | |
| Davol INC. | $12.95 | 2022 | |
| Arteriocyte Medical Systems, INC. | $10.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.